Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ownership Breakdown BioCryst Pharmaceuticals Inc. BCRX

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, with the aim of blocking key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedem...


Top institutional share ownership of BioCryst Pharmaceuticals, Inc.

Name Shares Shares % change Value Value % change
Vanguard Group Inc 13,838,612 0.2% $174,366 19.3%
BlackRock Inc. 13,774,995 -1.5% $173,565 17.3%
Baker Bros. Advisors Lp 12,710,818 0.0% $160,156 19.1%
State Street Corp 9,404,247 -14.5% $118,494 1.8%
Avoro Capital Advisors LLC 9,050,000 39.2% $114,030 65.8%
Fmr Llc 5,707,067 10.0% $71,910 31.0%
XBI - SPDR(R) S&P(R) Biotech ETF 5,645,990 -22.8% $71,139 -8.1%
VTSMX - Vanguard Total Stock Market Index Fund Investor Shares 5,588,361 2.2% $70,413 21.8%
Fisher Asset Management, LLC 5,163,845 -1.0% $65,064 17.9%
Pictet Asset Management Sa 4,813,772 -20.4% $60,653 -5.2%

Top institutional buyers of BioCryst Pharmaceuticals, Inc.

Name Shares % change Value % change Shares Value
Avoro Capital Advisors LLC 39.2% 65.8% 9,050,000 $114,030
Fmr Llc 10.0% 31.0% 5,707,067 $71,910
BNP Paribas Asset Management Holding S.A. 8.7% 29.4% 2,280,953 $28,740
Geode Capital Management, Llc 2.6% 22.1% 3,365,844 $42,409
VTSMX - Vanguard Total Stock Market Index Fund Investor Shares 2.2% 21.8% 5,588,361 $70,413
NAESX - Vanguard Small-Cap Index Fund Investor Shares 1.6% 21.0% 2,364,067 $29,787
Vanguard Group Inc 0.2% 19.3% 13,838,612 $174,366

Top institutional sellers of BioCryst Pharmaceuticals, Inc.

Name Shares % change Value % change Shares Value
Fairmount Funds Management LLC -23.9% -9.4% 2,543,107 $32,043
Victory Capital Management Inc -22.9% -8.2% 3,520,231 $44,355
XBI - SPDR(R) S&P(R) Biotech ETF -22.8% -8.1% 5,645,990 $71,139
Pictet Asset Management Sa -20.4% -5.2% 4,813,772 $60,653
FBIOX - Biotechnology Portfolio -16.1% -19.3% 3,649,042 $48,751
State Street Corp -14.5% 1.8% 9,404,247 $118,494
Artisan Partners Limited Partnership -9.2% 8.2% 2,649,616 $33,385
VEXMX - Vanguard Extended Market Index Fund Investor Shares -3.4% 15.1% 2,476,688 $31,206
Two Sigma Advisers, Lp -3.2% 15.2% 2,015,812 $25,399
IWM - iShares Russell 2000 ETF -2.9% 15.7% 4,059,300 $51,147

Information provided by Fintel.io